Laboratorios Farma | ROVI - Ebitda


Laboratorios Farma reported EUR34.94M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Almirall EUR 114.07M 60.37M Dec/2025
Avita Medical AUD -5.56M 4.13M Jun/2026
Dianthus Therapeutics USD -61.38M 14.92M Jun/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Moderna USD -1.26B 468M Mar/2026
Organon & Co USD 502M 131M Sep/2026
Pharma Mar EUR 9.63M 8.93M Sep/2026
Revvity USD 227.55M 629K Sep/2026
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1.2B 7.4M Sep/2026
Xeris Pharmaceuticals USD -20.94M 33.27M Jun/2026